摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

32-hydroxydotriacontanoic acid | 52900-19-3

中文名称
——
中文别名
——
英文名称
32-hydroxydotriacontanoic acid
英文别名
32-hydroxy-dotriacontanoic acid;32-Hydroxy-dotriacontansaeure;32-hydroxy dotriacontanoic acid;32-Hydroxy-docotriacontansaeure;omega-Hydroxydotriacontanoic acid
32-hydroxydotriacontanoic acid化学式
CAS
52900-19-3
化学式
C32H64O3
mdl
——
分子量
496.858
InChiKey
CTCQDFGRDYVMML-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    12.9
  • 重原子数:
    35
  • 可旋转键数:
    31
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.97
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    16-溴十六烷酸 16-bromohexadecanoic acid 2536-35-8 C16H31BrO2 335.325
    —— methyl 32-hydroxydotriacontanoate —— C33H66O3 510.885
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    —— oxacyclotritriacontan-2-one 81155-75-1 C32H62O2 478.843

反应信息

点击查看最新优质反应信息

文献信息

  • Process for preparing hydroxycarboxylic acids
    申请人:UNILEVER PLC
    公开号:EP0711746A1
    公开(公告)日:1996-05-15
    A new synthesis of ω-hydroxy acids, which employs commercially available starting materials and lowers the cost of production. The process involves coupling a fatty acyl group by enamine chemistry, followed by a ring expansion and selective reduction of ketoacid.
    一种新的ω-羟基酸合成法,它采用了市场上可买到的起始原料,并降低了生产成本。该工艺包括用烯胺化学方法偶联脂肪酰基,然后进行扩环和选择性还原酮酸。
  • Cosmetic compositions containing lactate dehydrogenase inhibitors
    申请人:UNILEVER PLC
    公开号:EP0722715B1
    公开(公告)日:2001-10-24
  • DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS
    申请人:Agrawal C. Mauli
    公开号:US20090123516A1
    公开(公告)日:2009-05-14
    Disclosed are medical devices comprising one or more surfaces, one or more SAM molecules attached to the one or more surfaces of the medical device, and one or more therapeutic agents attached to the one or more self-assembled monolayer molecules. Also disclosed are medical devices comprising one or more surfaces, one or more self-assembled monolayer molecules attached to the one or more surfaces of the medical device, one or more linkers comprising a first functional group and a second functional group, the first functional group attached to the self-assembled monolayer molecule and a therapeutic agent attached to the second functional group. The therapeutic agent may be attached to the SAM molecule via a linker. The present invention also concerns methods of administering a therapeutic agent to a subject, comprising contacting the subject with one of the medical devices set forth herein.
  • CONDENSATION POLYMERS WITH MODIFIED PROPERTIES
    申请人:Graichen Florian Hans Maximilian
    公开号:US20110136988A1
    公开(公告)日:2011-06-09
    The present invention relates to a method of preparing a polymer composition, the method comprising melt mixing an aliphatic condensation polymer with a cyclic ester of general formula (I) where X is an optionally substituted aliphatic hydrocarbon having 2 or more carbon atoms present in the cycle.
  • US5502226A
    申请人:——
    公开号:US5502226A
    公开(公告)日:1996-03-26
查看更多